Meningitis B Outbreak in Kent: What You Need to Know

A recent outbreak of Meningitis B in Kent, England, has triggered a public health response reminiscent of the early days of the COVID-19 pandemic, with students queuing for antibiotics and universities moving classes online. While the scenes evoke memories of recent health crises, experts emphasize key differences between Meningitis B and COVID-19. Here’s a breakdown of the situation, how the disease spreads and what measures are being taken to contain the outbreak.

What is Meningitis?

Meningitis is an inflammation of the meninges – the protective membranes covering the brain and spinal cord. It can be caused by both viral and bacterial infections. The current outbreak in Kent is caused by Neisseria meningitidis, a type of bacteria, specifically strain MenB. Approximately 10% of the population carries this bacteria in their nose and throat without becoming ill.

How is Meningitis B Spread?

Unlike the airborne spread of COVID-19, Meningitis B requires close, prolonged contact to transmit. Transmission occurs through activities like kissing, sharing drinks or vapes, or living in close quarters such as student accommodation. Dr. Eliza Gil, a clinical lecturer at the London School of Hygiene & Tropical Medicine, explains that the bacteria “don’t survive well outside of saliva droplets or respiratory secretions and, if coughed out, quickly sink to the floor.” This makes it significantly harder to contract than COVID-19.

Who is at Risk?

Meningitis is more common in babies, teenagers, and young adults. Babies are particularly vulnerable due to their developing immune systems. Teenagers and young adults are at higher risk due to their social behaviors and living conditions, with approximately 25% of this population carrying the bacteria.

The Kent Outbreak: What Happened?

The outbreak in Kent has been linked to Club Chemistry in Canterbury. As of Friday, March 20, 2026, 18 cases have been confirmed, with 11 under investigation, and tragically, two deaths have occurred – a student at the University of Kent and a year 13 pupil from Queen Elizabeth’s Grammar School in Faversham. The university has moved exams online, and St. Patrick’s Day events were cancelled as a precaution.

How is the Outbreak Being Contained?

Public health officials are employing a well-established response strategy. Those diagnosed with meningitis are hospitalized. Individuals at risk, including those who attended Club Chemistry, are being offered antibiotics to eliminate the bacteria from their nose and throat, preventing severe illness and further spread. The Bexsero MenB vaccine is as well being administered to provide protection against infection in the coming weeks. A targeted vaccination program is being rolled out for students in halls of residence at the University of Kent. The UK Health Security Agency (UKHSA) is also reviewing the general eligibility for the Meningitis B vaccine.

Is a COVID-Style Lockdown Likely?

Experts believe a widespread lockdown is unlikely due to the fundamental differences in how Meningitis B and COVID-19 spread. Professor Sir Andrew Pollard at the University of Oxford notes that public health officials have extensive experience with meningococcal disease, having tracked it for centuries.

Meningitis Vaccination History

Routine vaccination for Meningitis B was introduced for babies in the UK in 2015. While this protects infants during their most vulnerable first year, immunity is expected to wane by adolescence. Prior to the introduction of vaccines targeting MenC, England saw over 2,000 cases annually in the 1990s. Vaccination programs have dramatically reduced the incidence of meningococcal disease.